Cargando…
Outcomes of High Risk Patients with Febrile Neutropenia at a Tertiary Care Center
Fever during chemotherapy-induced neutropenia continues to be a major cause of morbidity and mortality in cancer patients. Mortality depends on the duration and degree of neutropenia, bacteremia, sepsis, performance status, comorbidities and other parameters. The highest mortality rates in cancer pa...
Autores principales: | Osmani, Asif Husain, Jabbar, Adnan Abdul, Gangwani, Manesh Kumar, Hassan, Bilal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747398/ https://www.ncbi.nlm.nih.gov/pubmed/29072402 http://dx.doi.org/10.22034/APJCP.2017.18.10.2741 |
Ejemplares similares
-
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018) -
Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital
por: Mohammed, Husnia Bedewi, et al.
Publicado: (2019) -
Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria
por: Salako, Omolola, et al.
Publicado: (2021) -
Risk factors for bacteremia in children with febrile neutropenia
por: KARA, Soner Sertan, et al.
Publicado: (2019) -
Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)